Call customer care on: 0333 358 0200
Dr Ruch Karunadasa

Authored on 01 December 2025 by Dr Ruch Karunadasa,

Reviewed 01 December 2025 by Dr Adeel Arshad.

9 Reasons You’re Not Getting the Best Results on GLP-1 Medications

With the Evidence

GLP-1 receptor agonists—such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound)—are proven treatments for weight management and type 2 diabetes. However, some people see slower or smaller changes than expected. Below are nine evidence-based reasons why results may vary, backed by current clinical guidance and research.

At PrivateDoc we guide patients on their weight loss journey and help you avoid the common pitfalls

1. Not Reaching the Maintenance Dose

GLP-1 treatments typically start at a low dose to reduce side effects, with gradual increases. If you remain on a starter dose for too long or haven’t titrated appropriately, results may be limited.
Why it matters: Most clinical trials showing significant weight loss used full therapeutic, or maintenance, doses.1,2

2. Irregular or Missed Doses

Missing doses or taking them at inconsistent intervals can blunt the medication’s effect.
Why it matters: GLP-1 medications rely on stable levels in your system to regulate appetite, digestion, and glucose control.3

3. Not Eating Enough Protein

Low protein intake can lead to muscle loss rather than fat loss.
Why it matters: Preserving lean muscle helps maintain metabolism and supports healthier, more sustainable weight loss.4

4. Drinking Too Many Liquid Calories

Alcohol, smoothies, juices, and speciality coffees can deliver large amounts of calories without making you feel full.
Why it matters: GLP-1 drugs reduce appetite, but they cannot offset high-calorie drinks.5

5. Eating High-Calorie, Low-Volume Foods

High-calorie, low-volume foods like chocolate, pastries, or takeaways can sabotage weight loss efforts.
Why it matters: GLP-1 medications help reduce appetite, but they cannot offset calorie-dense foods.6

6. Not Focusing on Strength Training

Without resistance training, the body may lose muscle along with fat.
Why it matters: Maintaining lean mass supports metabolism and long-term weight loss.7,8

7. Stress and Poor Sleep

Chronic stress and sleep deprivation can increase cravings and slow fat loss.
Why it matters: Cortisol and hormonal changes can undermine appetite control.9,10

8. Expecting Results Too Quickly

GLP-1 medications work gradually; maximum results are often seen after 9–12 months.
Why it matters: Weight loss continues progressively over many months with therapeutic doses.1,11

9. Underlying Medical Conditions or Other Medications

Conditions such as hypothyroidism, insulin resistance, perimenopause, or PCOS can slow results. Some medications (e.g., steroids, certain antidepressants, antipsychotics) may also influence weight.
Why it matters: Metabolic rate and weight loss can be affected by underlying conditions and concomitant medications.12,13

Summary

GLP-1 medications, such as semaglutide and tirzepatide, are highly effective tools for weight management when combined with proper dosing, consistent adherence, and healthy lifestyle habits. Achieving optimal results requires personalised clinical guidance, including dose adjustments and monitoring of nutrition and physical activity.

Consulting your PrivateDoc clinician ensures that your treatment plan is tailored to your individual needs, maximising weight loss opportunities while supporting long-term metabolic health.

References

  1. Wilding JPH, et al. STEP 1 Trial. New England Journal of Medicine, 2021.
  2. NICE Technology Appraisal TA875 — Semaglutide, 2023.
  3. Novo Nordisk. Wegovy Prescribing Information.
  4. Leidy HJ, et al. Higher protein intake preserves lean mass during weight loss. American Journal of Clinical Nutrition, 2015.
  5. DiMeglio DP, Mattes RD. Liquid calories and reduced appetite suppression. American Journal of Clinical Nutrition, 2000.
  6. Rolls BJ. High‑energy‑density foods increase calorie intake. Annual Review of Nutrition, 2009.
  7. AACE/ACE Obesity Clinical Practice Guidelines, 2016.
  8. ADA Standards of Care, 2024.
  9. Spiegel K, et al. Sleep restriction reduces leptin, increases ghrelin, and increases appetite. Annals of Internal Medicine, 2004.
  10. Jackson SE, et al. Stress increases calorie intake independent of hunger. Obesity Journal, 2017.
  11. Jastreboff AM, et al. SURMOUNT‑1 Trial. New England Journal of Medicine, 2022.
  12. Wilding JPH, et al. STEP Trials — sustained weight loss over many months. New England Journal of Medicine, 2021.
  13. NICE Guideline NG28 — Type 2 Diabetes, 2023.
  14. AACE Guidelines on Obesity, 2016.

How it works

Get personalised care
02. Get personalised care

We'll provide you with a tailored treatment plan from a UK registered doctor

Get next day delivery
03. Get next day delivery

Receive genuine medication shipped discreetly to your door